ReviewCancers2024

Sacituzumab Govitecan in Triple Negative Breast Cancer: A Systematic Review of Clinical Trials.

Marcelino Pérez-Bermejo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.